MVA Viral Vector Production
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract, issued by the NIH NCI under the Department of Health and Human Services, focuses on the engineering, production, and testing of an MVA vector encoding the gp70-Ii antigen. The scope of work includes large-scale production, purification, and functional validation to ensure the vector meets specific immunogenicity and safety standards. The project is categorized under NAICS code 541715 and is slated for performance in Oxford, UK. Interested parties must respond by August 24, 2026, following the posting date of August 17, 2026.
General Info
Agency
NAICS
Place of Performance
Oxford, GB-OXF, OX3 7DQ, GBRSet-Aside
Documents
This scope was carved out of 75N98026Q00996.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
Sole Source - Production of ChAdOx-1 and MVA expressing mouse gp70
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → NIH Nci
Same awarding agency
